Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Securis Investment Partners is a leading London-based investment manager specializing in insurance-linked securities (ILS). Founded in 2005, the firm manages assets across both Non-Life and Life insurance markets, offering institutional investors access to insurance-based risks that are generally uncorrelated with traditional financial markets. The firm's Life business specifically targets mortality, longevity, and lapse risks, providing capital solutions to the global life insurance and reinsurance industries. Securis operates as a financial services entity rather than a biotechnology or healthcare provider, focusing on the securitization of insurance cash flows. It is recognized as one of the largest independent managers in the ILS space, bridging the gap between capital markets and insurance risk.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Securis Investment Partners.